Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Studies suggest that botulinum A toxin is both effective and safe in bladder disorders

April 1, 2004

Studies reveal tolerability and efficacy of darifenacin in overactive bladder

April 1, 2004

BXL-353 inhibits testosterone-stimulated prostate growth in vivo

March 31, 2004

Stem cell therapy effective in urinary incontinence patients

March 31, 2004

Duloxetine demonstrates efficacy in women with stress urinary incontinence

March 31, 2004

Ranbaxy patents series of novel muscarinic receptor antagonists

March 31, 2004

Positive opinion handed down in Europe for duloxetine for SUI

March 30, 2004

FibroGen research supports HIF activation technology for acute renal failure

March 30, 2004

Novel PDE5 inhibitor for erectile dysfunction by Schering Plough

March 29, 2004

Merck to discontinue development of EMR-62203

March 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...